Discovery of lung cancer mutations responsive to targeted therapies, immunotherapies

Posted by on May 9, 2016 3:55 pm
Categories: health

A number of new driver mutations in lung cancer cells has been discovered that may be responsive to genomically targeted therapies and to immunotherapy.

Leave a Reply

Your email address will not be published. Required fields are marked *